Report cover image

Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Publisher QYResearch Group
Published Jan 21, 2022
Length 147 Pages
SKU # QYR16931625

Description

Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Summary

Market Analysis and Insights: Global Drug-Device Combination Products Market
The research report studies the Drug-Device Combination Products market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Drug-Device Combination Products market size is projected to reach US$ 117202 million by 2027, from US$ 76220 million in 2020, at a CAGR of 6.24% during 2021-2027.
Global Drug-Device Combination Products Scope and Segment
The global Drug-Device Combination Products market is segmented by company, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and By Application for the period 2016-2027.
By Company
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma

Segment by Type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer & Inhaler
Transdermal Delivery System
Other

Segment by Application
Hospital & Clinic
Retail Pharmacies
Other

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

Table of Contents

147 Pages
1 MARKET OVERVIEW OF DRUG-DEVICE COMBINATION PRODUCTS
1.1 Drug-Device Combination Products Market Overview
1.1.1 Drug-Device Combination Products Product Scope
1.1.2 Drug-Device Combination Products Market Status and Outlook
1.2 Drug-Device Combination Products Market Overview by Type
1.2.1 Drug-Coated Device
1.2.2 Prefilled Drug Delivery Systems
1.2.3 Nebulizer & Inhaler
1.2.4 Transdermal Delivery System
1.3 Global Drug-Device Combination Products Market Size by Type
1.3.1 Global Drug-Device Combination Products Market Size Overview by Type (2016-2027)
1.3.2 Global Drug-Device Combination Products Historic Market Size Review by Type (2016-2021)
1.3.3 Global Drug-Device Combination Products Forecasted Market Size by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
1.4.2 Europe Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
1.4.4 South America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
2 DRUG-DEVICE COMBINATION PRODUCTS MARKET COMPETITION BY COMPANY
2.1 Global Drug-Device Combination Products Market Size by Players (2019-2021)
2.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020)
2.3 Founded Date of Key Drug-Device Combination Products Players
2.4 Global Top Players Drug-Device Combination Products Headquarters and Area Served
2.5 Key Players Drug-Device Combination Products Product Solution and Service
2.6 Competitive Status
2.6.1 Drug-Device Combination Products Market Concentration Rate
2.6.2 Mergers & Acquisitions, Expansion Plans
3 DRUG-DEVICE COMBINATION PRODUCTS STATUS AND OUTLOOK BY REGION
3.1 Global Drug-Device Combination Products Market Size Overview by Region 2016 VS 2021 VS 2027
3.2 Global Drug-Device Combination Products Market Size by Region (2016-2027)
3.3 Global Drug-Device Combination Products Historic Market Size by Region (2016-2021)
3.4 Global Drug-Device Combination Products Market Size Forecast by Region (2022-2027)
4 DRUG-DEVICE COMBINATION PRODUCTS MARKET OVERVIEW BY APPLICATION
4.1 Drug-Device Combination Products Market Segment by Application
4.1.1 Hospital & Clinic
4.1.2 Retail Pharmacies
4.2 Global Drug-Device Combination Products Market Size by Application
4.2.1 Global Drug-Device Combination Products Market Size Overview by Application (2016-2027)
4.2.2 Global Drug-Device Combination Products Historic Market Size by Application (2016-2021)
4.2.3 Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
4.3.2 Europe Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
4.3.4 South America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
5 NORTH AMERICA
5.1 North America Drug-Device Combination Products Market Size by Country (2016-2027)
5.2 United States
5.3 Canada
5.4 Mexico
6 EUROPE
6.1 Europe Drug-Device Combination Products Market Size by Country (2016-2027)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Rest of Europe
7 ASIA-PACIFIC
7.1 Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2027)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 SOUTH AMERICA
8.1 South America Drug-Device Combination Products Market Size by Country (2016-2027)
8.2 Brazil
8.3 Rest of South America
9 MIDDLE EAST & AFRICA
9.1 Middle East & Africa Drug-Device Combination Products Market Size by Country
9.2 Middle East
9.3 Africa
10 COMPANY PROFILES AND KEY FIGURES IN DRUG-DEVICE COMBINATION PRODUCTS BUSINESS
10.1 GSK
10.1.1 GSK Corporation Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.1.4 GSK Drug-Device Combination Products Offered
10.1.5 GSK Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Corporation Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.2.4 Novo Nordisk Drug-Device Combination Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Corporation Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.3.4 Eli Lilly Drug-Device Combination Products Offered
10.3.5 Eli Lilly Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Corporation Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.4.4 AstraZeneca Drug-Device Combination Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Sanofi
10.5.1 Sanofi Corporation Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.5.4 Sanofi Drug-Device Combination Products Offered
10.5.5 Sanofi Recent Development
10.6 Boston Scientific
10.6.1 Boston Scientific Corporation Information
10.6.2 Boston Scientific Introduction and Business Overview
10.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.6.4 Boston Scientific Drug-Device Combination Products Offered
10.6.5 Boston Scientific Recent Development
10.7 Abbott
10.7.1 Abbott Corporation Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.7.4 Abbott Drug-Device Combination Products Offered
10.8 Boehringer Ingelheim
10.8.1 Boehringer Ingelheim Corporation Information
10.8.2 Boehringer Ingelheim Introduction and Business Overview
10.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.8.4 Boehringer Ingelheim Drug-Device Combination Products Offered
10.8.5 Boehringer Ingelheim Recent Development
10.9 Medtronic
10.9.1 Medtronic Corporation Information
10.9.2 Medtronic Introduction and Business Overview
10.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.9.4 Medtronic Drug-Device Combination Products Offered
10.9.5 Medtronic Recent Development
10.10 Mylan
10.10.1 Mylan Corporation Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.10.4 Mylan Drug-Device Combination Products Offered
10.10.5 Mylan Recent Development
10.11 3M
10.11.1 3M Corporation Information
10.11.2 3M Introduction and Business Overview
10.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.11.4 3M Drug-Device Combination Products Offered
10.12 Hisamitsu
10.12.1 Hisamitsu Corporation Information
10.12.2 Hisamitsu Introduction and Business Overview
10.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.12.4 Hisamitsu Drug-Device Combination Products Offered
10.13 Smith & Nephew
10.13.1 Smith & Nephew Corporation Information
10.13.2 Smith & Nephew Introduction and Business Overview
10.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.13.4 Smith & Nephew Drug-Device Combination Products Offered
10.13.5 Smith & Nephew Recent Development
10.14 Molnlycke
10.14.1 Molnlycke Corporation Information
10.14.2 Molnlycke Introduction and Business Overview
10.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.14.4 Molnlycke Drug-Device Combination Products Offered
10.15 Teleflex
10.15.1 Teleflex Corporation Information
10.15.2 Teleflex Introduction and Business Overview
10.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.15.4 Teleflex Drug-Device Combination Products Offered
10.15.5 Teleflex Recent Development
10.16 BD
10.16.1 BD Corporation Information
10.16.2 BD Introduction and Business Overview
10.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.16.4 BD Drug-Device Combination Products Offered
10.17 Lepu Medical
10.17.1 Lepu Medical Corporation Information
10.17.2 Lepu Medical Introduction and Business Overview
10.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.17.4 Lepu Medical Drug-Device Combination Products Offered
10.18 MicroPort
10.18.1 MicroPort Corporation Information
10.18.2 MicroPort Introduction and Business Overview
10.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.18.4 MicroPort Drug-Device Combination Products Offered
10.19 Terumo
10.19.1 Terumo Corporation Information
10.19.2 Terumo Introduction and Business Overview
10.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.19.4 Terumo Drug-Device Combination Products Offered
10.20 B. Braun
10.20.1 B. Braun Corporation Information
10.20.2 B. Braun Introduction and Business Overview
10.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.20.4 B. Braun Drug-Device Combination Products Offered
10.21 Antares Pharma
10.21.1 Antares Pharma Corporation Information
10.21.2 Antares Pharma Introduction and Business Overview
10.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
10.21.4 Antares Pharma Drug-Device Combination Products Offered
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
11.1 Drug-Device Combination Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Market Concentration Rate
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug-Device Combination Products Industrial Chain Analysis
11.4 Drug-Device Combination Products Market Dynamics
11.4.1 Drug-Device Combination Products Industry Trends
11.4.2 Drug-Device Combination Products Market Drivers
11.4.3 Drug-Device Combination Products Market Challenges
11.4.4 Drug-Device Combination Products Market Restraints
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
12.1 Sales Channel
12.2 Drug-Device Combination Products Distributors
12.3 Drug-Device Combination Products Downstream Customers
13 RESEARCH FINDING/CONCLUSION
14 METHODOLOGY AND DATA SOURCE
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Tables
Table 1. Major Company of Drug-Coated Device
Table 2. Major Company of Prefilled Drug Delivery Systems
Table 3. Major Company of Nebulizer & Inhaler
Table 4. Major Company of Transdermal Delivery System
Table 5. Global Drug-Device Combination Products Revenue by Type: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
Table 7. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021)
Table 8. Global Drug-Device Combination Products Revenue by Type (2022-2027) & (US$ Million)
Table 9. Global Drug-Device Combination Products Revenue Market Share by Type (2022-2027)
Table 10. North America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
Table 11. Europe Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
Table 12. Asia-Pacific Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
Table 13. South America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
Table 14. Middle East and Africa Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
Table 15. Global Drug-Device Combination Products Revenue (US$ Million) by Players (2019-2021)
Table 16. Global Drug-Device Combination Products Revenue Market Share by Players (2019-2021)
Table 17. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020)
Table 18. Founded Date of Key Drug-Device Combination Products Players
Table 19. Global Drug-Device Combination Products Top Players Headquarters and Area Served
Table 20. Drug-Device Combination Products Product Solution and Service
Table 21. Global Drug-Device Combination Products Players Market Concentration Ratio (CR5 and HHI)
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Market Drug-Device Combination Products Market Size (US$ Million) Comparison by Region: 2016 VS 2021 VS 2027
Table 24. Global Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million)
Table 25. Global Drug-Device Combination Products Market Size Share by Region (2016-2021)
Table 26. Global Drug-Device Combination Products Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 27. Global Drug-Device Combination Products Forecasted Market Size Share by Region (2022-2027)
Table 28. Global Drug-Device Combination Products Market Size (US$ Million) By Application: 2016 VS 2021 VS 2027
Table 29. Global Drug-Device Combination Products Market Size by Application (2016-2021) & (US$ Million)
Table 30. Global Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
Table 31. Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 32. Global Drug-Device Combination Products Revenue Market Share by Application (2022-2027)
Table 33. North America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
Table 34. Europe Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
Table 35. Asia-Pacific Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
Table 36. South America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
Table 37. South America Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
Table 38. Middle East and Africa Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
Table 39. North America Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Drug-Device Combination Products Market Share by Country (2016-2021)
Table 44. Europe Drug-Device Combination Products Market Share by Country (2022-2027)
Table 45. Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million)
Table 46. Asia-Pacific Drug-Device Combination Products Market Size by Region (2022-2027) & (US$ Million)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us